Profil
Dawn Schottlandt worked as VP-Investor Relations & Corporate Communications at ArQule, Inc. from 2015 to 2018 and at Chiasma, Inc. from 2019 to 2020.
She completed her undergraduate degree at Boston College.
Ehemalige bekannte Positionen von Dawn Schottlandt
| Unternehmen | Position | Ende |
|---|---|---|
| CHIASMA, INC. | Investor Relations Kontakt | 01.07.2020 |
| ARQULE, INC. | Investor Relations Kontakt | 01.01.2018 |
Ausbildung von Dawn Schottlandt
| Boston College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
